The use of the [Mo(3)S(4)(Hnta)(3)](2-) complex (nta(3-) = nitrilotriacetate) as structuring agent toward the self-condensation process of the [Mo(2)O(2)S(2)(OH(2))(6)](2+) cation leads to the largest oxothiomolybdenum ring. In the solid state, X-ray diffraction analysis reveals the presence of the targeted molecular compound (noted 1a), which consists of the {Mo(18)O(18)S(18)(OH)(18)} host templated by the [Mo(3)S(4)(Hnta)(3)](2-) guest. Nevertheless, the structure shows an additional molecular moiety corresponding to a dinuclear unit {Mo(2)O(2)S(2)} coordinated to two nta(3-) ligands, mutually arranged in a cis fashion (1b). In the solid state, both entities interact through two short hydrogen bonds to give a striking supramolecular adduct, noted {1a-1b}. Synthetic procedures to prepare the individual species as pure compounds were reported. 1a was obtained as a pure mixed Cs(+)/NMe(4)(+) salt while the dinuclear unit [Mo(2)O(2)S(2)(Hnta)(2)](2-) was obtained as mixed K(+)/Na(+) crystals. X-ray diffraction study of the latter reveals a trans isomer (noted 1b'), characterized by the specific coordination of both nta(3-) ligands. All the compounds were characterized in solution (D(2)O or DMSO) by multiexperiment (1)H NMR (1D, COSY, NOESY, and DOSY). The overall results were consistent with the retention of the adduct {1a-1b} which exhibits a supramolecular reactivity. The dinuclear individual species in solution gave rise to cis-trans equilibrium, while in the presence of the oxothiomolybdenum ring 1a, the dinuclear unit is maintained as a frozen cis complex. DOSY NMR provides a definitive argument for the integrity of the supramolecular assembly. In addition, preliminary electrochemical study of 1a is also reported.
No takes yet. Share an insight, caveat, or question.
Duval et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: